Mumbai, July 28, 2018: Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY) announced today that it has launched Hervycta® (Trastuzumab), a…
New Delhi, May 18, 2018: Patients in Cuba will have better access to therapy for lymphoma and rheumatoid arthritis The…
Mumbai, Janaury 04, 2018: Biotechnology mAJOR, Biocon and Mylan have received approval for Biosimilar Trastuzumab from ANVISA, the Brazilian regulatory agency,…